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Abstract
Prolonged and intensive exercise induces transient immunosuppression and is associated with 
an increased risk and severity of infections. The goal of this study was to characterize the 
antiviral and antibacterial properties of the bioactive metabolites of a blueberry–green tea-
polyphenol soy protein complex (PSPC) in the serum of supplemented subjects during a 3-day 
intensified training period. Long-distance runners, randomly divided into two groups, ingested 
40 g/day PSPC or placebo (soy protein and colorings) for 17 days, with a 3-day running period 
inserted at day 14. Blood serum samples were collected pre-14 days and post-14 days 
supplementation, and immediately and 14 h after the third day of running. The post-exercise 
serum from both groups significantly promoted the growth of Escherichia coli and 
Staphylococcus aureus in culture by 20–70%, but returned to normal levels following recovery. 
Furthermore, the serum from subjects ingesting PSPC did not display antibacterial properties at 
any time point. In contrast, there was a significant difference in the ability of serum from PSPC-
supplemented versus placebo-supplemented athletes to protect cells in culture from killing by 
vesicular stomatitis virus following strenuous exercise. In addition, the serum of subjects who 
ingested PSPC significantly delayed an exercise-induced increase in virus replication. These 
results indicate that polyphenol complexes containing blueberry and green tea have the 
potential to protect athletes from virus infections following rigorous exercise. 
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nols are abundant micronutrients in our diet Polyphe
and are widespread constituents of fruits, vegetables, 
cereals, chocolates and beverages such as tea, coffee, d wine. Numerous studies have revealed that 
nols exert beneficial effects on human health, 
g antioxidant, anti-inflammatory and anti-cancer 
(Gonzalez-Vallinas et al., 2013; Khurana et al., 
ndete, 2012). Furthermore, polyphenols derived 
ious sources have been reported to exert activity 
 variety of infectious organisms such as respira-
ually transmitted and food-borne viruses, and 
nic bacterial strains (Andrae-Marobela et al., 
aglia, 2012; Fioravanti et al., 2012; Li et al., 2013). 
r, much of the evidence on the prevention of 
 and infections by polyphenols is derived from 
or animal studies that are often performed with 
uch higher than those available to humans. Fur-
e, polyphenols are extensively metabolized by 
l and hepatic enzymes and by the intestinal mi-
to generate circulating conjugated derivatives that 
e available to target tissues (Del Rio et al., 2013). Therefore, in vitro studies with polyphenolic extracts
may fail to accurately evaluate the effects of the various
derivatives in humans.
The goal of the current study was to determine whether 
the serum of subjects ingesting a high-dose polyphenol 
supplement would provide protective activity against viral 
and bacterial infections following a 3-day intensified train-
ing regimen. During strenuous exercise, there is a dramatic 
increase in reactive oxygen species production resulting in 
oxidative stress (Powers and Jackson, 2008). Exhaustive 
exercise also induces structural damage to muscle cells, 
inflammation and immune dysfunction. Transient immu-
nosuppression induced by prolonged, intense exercise is 
reported to increase the risk of acquiring respiratory 
tract infections in humans (Martin et al., 2009; Nieman, 
1994). Therefore, there is great interest in evaluating 
the anti-microbial effects of polyphenols during strenu-
ous exercise-induced immune dysfunction in humans.
A number of epidemiological studies have attempted 
to determine the effects of specific intensities and dura-
tions of exercise on the incidence of upper respiratory 
tract infections in humans (Ekblom et al., 2006; Nieman 
et al., 1989; Nieman et al., 1990). However, because of 
ethical constraints, there are limited studies that have d whether polyphenolic compounds exert pro-
ffects against infectious organisms during stren-
ercise in humans. We have developed in vitro 
 evaluate the antiviral and antibacterial activity 
erum of individuals supplemented with a blue-
d green tea-polyphenol-rich soy protein-based
complex (PSPC). This study expands on the work done
by Nieman et al. in which they determined that 17 days
of supplementation with the PSPC compound caused a
distinct gut-derived phenolic signature in long-distance
runners following a 3-day period of intensified running
(Nieman et al., 2013). However, PSPC supplementation
did not alter conventional biomarkers for inflammation
and oxidative stress at any point during the study. By
testing the effect of PSPC supplementation on the
growth properties of specific bacteria and viruses and
their impact on cell killing, we determined that serum
factors circulating after ingestion of green tea and blue-
berries have the capacity to exert antiviral activity.MATERIALS AND METHODS
Subjects and research design. Subject recruitment was
conducted as described previously (Nieman et al., 2013).
Subjects were recruited by the Human Performance
Laboratory Research Manager, and included 38 healthy,
non-smoking long-distance male or female runners ages
19–45 years who regularly competed in marathon and
half-marathon road races and were capable of running
2.5 h at high intensity on laboratory treadmills. During
the study, subjects consented to train normally, maintain
weight and avoid the use of medications known to affect
inflammation and immune function for the duration of
the study. All vitamin and mineral supplements above
100% the U.S. Daily Value were also avoided. Runners
(N=35) were randomized by the research manager and
divided into the PSPC (N=17) or placebo groups (N=18),
with supplements administered over a 17-day period
using double-blinded methods and a parallel group
design. All other investigators, study personnel and
subjects were blinded to the type of supplement used
by the two groups during the study. All subjects signed
informed consent forms, and all study procedures were
approved by the Institutional ReviewBoard atAppalachian
State University (ASU). Data were analyzed from subjects
completing all aspects of the study (N=16 PSPC, N=15
placebo). The study was conducted during the winter/
spring of 2012 at theASUHuman Performance Laboratory
at theNorthCarolinaResearchCampus inKannapolis, NC.Supplementation complex and procedures. Green tea
extract (product# Std +101) was purchased from Finlay
Tea Solutions US Inc. (Florham Park, NJ, USA). LiquidFigure 1. Research design. Thirty-one randomized runners ingested polyp
2weeks and then completed 3 consecutive days of intense bouts of 2.
indicated.blueberry pomace water extract was a gift from Milne
Fruit (Prosser, WA, USA). Soy protein isolate (SPI)
was obtained from Archer Daniels Midland (Ardex F,
ADM, Decatur, IL, USA). All clinical trial study mate-
rials were provided by Nutrasorb LLC (North Brunswick,
NJ, USA), and supplements prepared by the Dole Nutri-
tionResearch Institute. Blueberry polyphenol soy protein
complex (22 kg) and green tea-polyphenol soy protein
complex (8kg) were produced individually as previously
described (Nieman et al., 2013), and then blended to ob-
tain a 3:1 blueberry–green tea PSPC. The total polyphe-
nolic levels and individual catechin contents remained
stable for greater than 12months storage at 5 °C in the
dark due to the stable protein polyphenolic matrix
(Nieman et al., 2013). Placebo was prepared from SPI,
with non-polyphenolic food colorings (mixture of FD&C
Blue #1 and FD&C Re #40) added to approximate the
purple hue of PSPC.
Supplementation took place over a 17-day period,
including a 14-day pre-exercise period, followed by a
3-day intensified exercise period. Subjects were ran-
domized to PSPC or placebo (parallel group design,
double-blinded treatments), and consumed 20g mixed in
237mL water in the morning, and then 20 g again at lunch
(thus 40g/day). Overall, the effective daily dose of PSPC
(40 g) corresponded to 2136mg Gallic Acid Equivalents
(GAEs) or the equivalent of 3 cups of blueberries and 1.5
cups of brewed green tea (Nieman et al., 2013). Compliance
to the supplementation regimenwas checked through email
messages and during the post-supplementation lab visits.Exercise sessions. Polyphenol soy protein complex and
placebo groups did not differ significantly in age
(33.7 ± 1.7 and 35.2 ± 2.2 years, respectively, P= 0.593)
and VO2max (57.2 ± 1.8 and 54.3 ± 1.6 years, respectively,
P=0.232). Subjects in both groups trained normally during
the 2-week supplementation (average 49.0±2.7 km/week)
and then participated in a 3-day period of intensified exer-
cise (Fig. 1). In the morning of the first intensified exercise
session, subjects consumed the normal supplement portion
(20 g PSPC or placebo in 237mL water) and breakfast
(ad libitum). A standardized meal consisting of Boost
Plus at 10 kcal/kg was ingested at 12:00 noon. Boost Plus
is manufactured by Nestle (Vevey, Switzerland) and has
an energy density of 1.5 kcal/mL (50% energy as carbo-
hydrate, 35% fat and 15% protein). The normal lunch-
time PSPC or placebo supplement was delayed until
after the blood draw at 2:30 PM. Subjects reported to
the Human Performance Laboratory at 2:30 PM andhenol soy protein complex (PSPC) (N=16) or placebo (N=15) for
5 h exercise at 90–75% VO2max. Blood samples were collected as
provided blood samples in a rested, seated position. Sub-
jects next ingested the PSPC or placebo supplement
dose. At 3:00 PM, subjects ran on treadmills for 2.5 h at
approximately 70% VO2max. Water was given ad libitum
throughout the 2.5-h exercise bouts, with no other bever-
age or food allowed. Subjects ingested another 20 g dose
of PSPC or placebo mixed in water after 1 hour of exer-
cise. Heart rate, rating of perceived exertion and dis-
tance run were recorded every 30min during the bout,
with oxygen consumption and ventilation measured
after 1 h of exercise (Cosmed FitMate metabolic system,
Rome, Italy). No group differences in metabolic mea-
sures were found for the 2.5-h exercise periods over the
3-day intensified exercise period. For PSPC and placebo
groups, 3-day averages during 7.5h running on level tread-
mills for heart rate (HR) were 152±3.8 (82.1±0.9%
HRmax) and 151 ± 2.5 bpm (84.2 ± 0.9% HRmax), respec-
tively (P= 0.930), oxygen consumption (VO2) were
37.8 ± 1.0 (66.5 ± 1.8% VO2max) and 36.5 ± 0.8mLkg1
min1 (67.8 ± 2.0% VO2max), respectively (P= 0.326),
and distances run were 25.3 ± 0.7 and 25.0 ± 0.5 km/day,
respectively (P= 0.777). Subjects repeated this schedule
for the next 2 days but without pre-exercise blood draws.
Blood samples were taken immediately following the third
exercise bout on the third day and 14-h post-exercise the
following morning. In total, four samples of blood were
collected from each subject (pre-supplementation, pre-
exercise, post-3day exercise and 14-h recovery) as indi-
cated in Fig. 1. Bloodwas collected in serum separator tubes
and allowed to clot for 30min. Following centrifugation,
serum was aliquoted and stored at 80 °C until use.Antibacterial activity. Serum samples from PSPC-
supplemented and placebo-supplemented subjects were
assessed for their ability to affect the growth of select
bacteria. Serum samples at each time point were heat-
inactivated for 30min at 56 °C (HI-serum) to prevent
the complication of complement-mediated cell lysis.
HI-serum samples were diluted at a 1:2 ratio with LB
bacterial nutrient broth (Fisher Scientific) and incubated
with 20μL of overnight cultures of Escherichia coli
(E. coli) strain K-12 or coagulase-positive Staphylococcus
aureus (S. aureus), a BSL2 pathogen, both obtained from
Carolina Biological Supply Company (Burlington, NC,
USA). Controls included serum-alone samples, bacteria-
alone samples (growth control), nutrient broth samples
(sterility control) and bacteria grown in the presence of
128μg/mL of ampicillin (obtained from Fischer Scientific).
All experimental and control cultures were incubated at
37 °C for 24 h, at which time samples were carefully re-
suspended and transferred to a 96-well dish. Absorbance
readings at 600 nm were measured using the Molecular
Devices SoftMax Pro 5 microplate reader. Data were
quantitated by dividing the experimental samples (ex-
perimental minus serum alone) by the growth control
samples (growth control minus sterility control). These
values were then normalized to the pre-supplementation
values in order to more clearly observe changes follow-
ing supplementation, exercise and recovery periods.Cells and virus.HeLa cervical cancer cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM) con-
taining 7.5% fetal bovine serum (FBS). HeLa cells wereused for our study because of their robust growth prop-
erties and their susceptibility to infection by vesicular
stomatitis virus (VSV).
Vesicular stomatitis virus is a prototype of negative
strand RNAviruses such as rabies virus and Ebola virus.
It is highly cytopathic for cells from a variety of different
species, including neurons and respiratory epithelial
cells, thus making it a desirable model for the study of
pathogenic viruses.Recombinantwild-typeVSV (rwt virus)
contains genes from several wt strains of VSV. Rwt virus
and recombinant VSVexpressing EGFP (green fluorescent
protein) as a foreign gene (rwt-GFP virus) have been de-
scribed previously (Whitlow et al., 2006). Virus stocks were
prepared in HeLa cells using methods described previously
(Kopecky et al., 2001). For all virus infections, HeLa cells
were infected in DMEM with 7.5% FBS at a multiplicity
of infection (MOI) of 3 PFU/cell.
Antiviral activity. To investigate whether serum from test
subjects exhibited antiviral activity, the ability of VSV to
kill permissive cells in the presence of various concentra-
tions of serum was determined by MTT (3-(4, 5-
dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide)
assay. Specifically, HeLa cells, susceptible to infection by
VSV, were grown in 96-well dishes (in DMEM plus
7.5% FBS) until they reached approximately 70–80%
confluency. At this time, cells were incubated with HI-
serum at a serum to media ratio of 1:2. At various times
post-incubation (0 and 4h), cells were infected with rwt
virus at a MOI of 3 plaque-forming unit (pfu)/cell. Cells
were assessed for viability using MTT assay (MTT Cell
Proliferation Kit, Roche Diagnostics) at 24 and 48h
post-infection. Controls included incubation of cells with
serum alone (serum-alone samples) to measure potential
cytotoxic effects of the serum, virus alone (virus-alone
samples) to determine the cytotoxic effect of virus, and
untreated and uninfected cells (mock) as background
controls. Data were quantitated by dividing the values
obtained from each sample by the mock value. All data
were then normalized to the serum-alone data to adjust
for differences in the serum responses between subjects.
As defined previously, these values were then normalized
to the pre-supplementation values.
Virus replication. To determine the effect of serum from
test subjects on the replication capacity of VSV,HeLa cells
were grown in 6-well dishes until they reached 70–80%
confluency. As described earlier, cells were incubated with
HI-serum at a serum to media ratio of 1:2. At 4h post-
incubation, cells were infected with rwt-GFP at a MOI of
3pfu/cell. At 6 and 12h post-infection, cells were washed,
harvested in PBS and subjected to flow cytometry to mea-
sure the fluorescence of GFP within cells. Two parameters
were measured: (1) the percentage of cells expressing
GFP, as an indication of the number of cells supporting
virus replication, and (2) the geometricmean fluorescence,
measuring the degree of replication within cells. All data
were normalized to the pre-supplementation values.
Statistical methods. All data are expressed as mean± stan-
dard error. Data were compared between groups at each
time point using Student’s t-test, with comparisons between
time points within a group compared using paired t-test.
RESULTS
Effect of polyphenol soy protein complex on bacterial
growth
Several studies have investigated the effects of phyto-
chemicals found in blueberries and green tea on inhibi-
tion of pathogenic bacteria. Various berry extracts have
been shown to inhibit the growth of uropathogenic bacte-
ria such as Helobacter pylori and E. coli (Guay, 2009;
Roopchand et al., 2012; Zafra-Stone et al., 2007). The
main constituent of green tea, epigallocatechin-3-gallate
(EGCG), has been reported to have anti-infective prop-
erties against S. aureus strains using multiple mechanisms
(Steinmann et al., 2013). Data in Fig. 2 show that there
was no significant difference in the growth of E. coli
(Fig. 2A) or S. aureus (Fig. 2B) in the presence of serum
from placebo-supplemented versus PSPC-supplemented
subjects. However, we observed a significant exercise-
induced increase in bacterial growth of E. coli in both
the placebo (58% increase, P=0.005) and PSPC (71% in-
crease, P=0.006) groups, and S. aureus in the placebo
group (23% increase, P=0.033), which decreased during
the recovery period. These data indicate that intense
and prolonged exercise leads to increased susceptibility
to bacterial infection that is not ameliorated by PSPC.Antiviral effects of polyphenol soy protein complex
supplementation
In addition to negatively impacting the growth of bacteria,
polyphenols have also been reported to possess antiviral
activity. The antiviral activities of ECGC with different
modes of action have been demonstrated for important
human pathogens such as HIV and influenza virus
(Andrae-Marobela et al., 2013; Fioravanti et al., 2012).
In addition, in vitro studies have shown that ECGC at
physiological concentrations interferes with the replica-
tion cycles of DNA viruses like hepatitis B virus, herpes
simplex virus and adenovirus (Steinmann et al., 2013). In
order to measure the antiviral activity in serum from
PSPC-supplemented and placebo-supplemented individ-
uals, we exposed HeLa cells to serum and evaluated its
ability to protect cells against killing by VSV. ToFigure 2. Growth of bacteria in the presenceof serum frompolyphenol soy
subjects. Escherichia coli (A) or Staphylococcus aureus (B) was incuba
determined by measuring absorbance readings at 600nm. All readings wdetermine the dose of VSV used for the experiments,
HeLa cells were infected with rwt virus at MOIs of 0.3
and 3pfu/cell, and cell viability was measured at 24 and
48h post-infection (Fig. 3A). At the lower dose of virus
(MOI 0.3 pfu/cell), HeLa cells succumbed to killing by
rwt virus only when infected for 48h. However, when in-
fected at a MOI of 3 pfu/cell, cells were highly susceptible
to the cytopathic effect of VSV such that less than 20% of
cells remained viable by 24h. For the subsequent experi-
ments (Fig. 3C and D), we chose to infect cells at an
MOI of 3pfu/cell for 24h in order to measure any poten-
tial antiviral activity in serum samples.
There was no difference in the effect of serum alone from
PSPC- (N= 16) versus placebo-supplemented (N= 15)
subjects on cell viability (Fig. 3B). Furthermore, serum
alone did not inhibit the viability of HeLa. In fact, there
was a slight increase in cell viability following exercise in
both sample groups. To measure the effect of serum on
the viability of cells following virus infection, data were
normalized to serum-alone samples and expressed rela-
tive to the pre-supplementation values (Fig. 3C and D).
Serum from subjects who ingested PSPC protected cells
from the exercise-induced susceptibility to killing by
rwt virus, as indicated by the significant post-exercise dif-
ferences in cell viability between the two groups. This re-
sult was obtained when cells were incubated with serum
for 0 (Fig. 3C) and 4h (Fig. 3D) prior to virus infection.
Furthermore, pre-incubating cells for 4 h with serum from
PSPC-supplemented individuals also provided protection
from virus infection following the 14-h recovery period.
These data provide evidence that the serum of individuals
ingesting PSPC contains antiviral properties that allow
cells to resist virus infections following strenuous exercise.Effect of polyphenol soy protein complex
supplementation on virus replication
To further analyze the antiviral effects of PSPC-supplemented
serum, the impact of serum on virus replication was mea-
sured. For these experiments, cells were infected with an
rwt virus strain engineered to express green fluorescent
protein (rwt-GFP) during its replication cycle (Whitlow
et al., 2006). At 6 h post-infection, a lower percentage
of cells expressed GFP when incubated with serum ob-
tained from PSPC versus placebo subjects immediatelyprotein complex (PSPC)-supplemented versus placebo-supplemented
ted with PSPC or placebo serum for 24h. Growth of bacteria was
ere normalized to the pre-supplementation values.
Figure 3. Antiviral activity in the serum from test subjects. HeLa cells were infected with serum from polyphenol soy protein complex
(PSPC)-supplemented or placebo-supplemented subjects for different times and infected with rwt virus. Cell viability was measured by
MTTassay. Controls included cells infected with virus alone or incubated with serum alone. All data were normalized to mock-infected cells.
(A) Susceptibility of HeLa cells following infection with rwt virus at MOIs of 0.3 or 3pfu/cell for 24 or 48h. (B) Impact of serum alone on
viability of HeLa cells (24h). (C and D) Cells were incubated with serum from subjects for 0 (C) or 4 h (D), followed by vesicular stomatitis
virus infection (rwt virus) for 24h. Data were normalized to mock-infected cells and expressed relative to the pre-supplementation values.post-exercise (P= 0.061) and at the 14-h recovery time
period (P= 0.038) (Fig. 4A). This difference was not
observed by 12 h post-infection (Fig. 4B). Consistent
with this result, at 12 h post-infection, the geometric
mean fluorescence was lower in the cells exposed to se-
rum from PSPC-supplemented individuals as compared
with serum from placebo subjects following exercise
(Fig. 4D). These results imply that there was delay in
virus infection when cells were incubated with PSPC
versus placebo serum, as indicated by the 6 h result in
Fig. 4A. Although virus recovered its ability to infect
cells by 12 h post-infection, the degree of replication
within cells was significantly lower during that time, as
indicated by the geometric mean fluorescence data in
Fig. 4D. Overall, we can conclude that PSPC serum
contains factors that interfere with the ability of virus
to effectively infect and replicate within cells. The effect
of PSPC serum on virus replication is also consistent with
the lowered impact of the virus on cell death, as shown in
Fig. 3.DISCUSSION
Numerous epidemiological and observational studies
have suggested a link between strenuous exercise and
increased susceptibility to virus infections in humans
(Martin et al., 2009; Nieman, 1994). Controlled animal
studies have also supported this hypothesis. For example,exercise stress has been shown to be associated with an
increased incidence and severity of HSV-1 and influenza
respiratory infections (Brown et al., 2007; Murphy et al.,
2008). Although various nutritional strategies have been
investigated as a countermeasure to immune dysfunction
during prolonged bouts of intense exercise, there is lim-
ited evidence that any of these strategies provide protec-
tion against susceptibility to infections. The results of our
ex vivo studies indicate a protective effect of a PSPC on
virus infectivity during a timewhen athletes are transiently
immune-suppressed and susceptible to virus infections.
Furthermore, the fact that serum from subjects ingesting
PSPC significantly protects cells from the cytopathic
effects of virus infection suggests that ingesting PSPC
provides the body with soluble factors that have the
potential to act systemically and target infections at dif-
ferent anatomical locations following strenuous exercise.
The mechanism by which PSPC and other flavonoids
provide protection from virus infections remains to be
determined. Cell culture studies have shown that the
polyphenol, quercetin, inhibits the replication of several
respiratory viruses, including influenza virus, adenovi-
ruses and rhinoviruses, by targeting an early step in
the virus infectious cycle (Cushnie and Lamb, 2005;
Kim et al., 2010; Selway, 1986). Consistent with this
observation, we found that pre-incubation of cells with
serum from PSPC-supplemented individuals for 4 h pro-
vided significant and sustained protection against killing
by VSV, whereas the addition of serum at 0 h following
viral infection did not result in sustained antiviral
Figure 4. Replication of vesicular stomatitis virus in HeLa cells in the presence of serum from polyphenol soy protein complex (PSPC)-
supplemented or placebo-supplemented subjects. HeLa cells were incubated with serum from PSPC or placebo subjects for 4h and infected
with rwt-GFP virus. At 6 or 12h post-infection, GFP expression was measured by flow cytometry. Data were expressed as the percentage of
cells expressing GFP at 6 (A) or 12h (B) and the geometric mean fluorescence at 6 (C) and 12h (D). All results were normalized to mock
samples and expressed relative to the pre-supplementation values.activity during the recovery period. This result suggests
that PSPC in serum must induce antiviral activity prior
to virus infection of cells in order to target and inhibit
the early steps of the virus replication cycle. Proposed
mechanisms for this suppression include blockage of vi-
rus binding to the host cell plasma membrane, alteration
of essential viral proteins and induction of cellular anti-
viral responses targeting specific steps in the viral repli-
cation cycle.
Studies with influenza virus and hepatitis C virus
(HCV) have attributed the antiviral effect of EGCG, a
catechin found in green tea, to interference of viral pen-
etration into cells due to damage of the virus particle
(Calland et al., 2012; Kim et al., 2013). Defective inter-
nalization may be due to alteration of viral glycopro-
teins or physical damage to the viral particles, possibly
the viral membrane. Similar to influenza virus and
HCV, VSV is an enveloped virus that may also be sus-
ceptible to the damaging effects of EGCG. The cell sur-
face receptors for VSV have not been identified, but
binding of VSV to cells is thought to be unspecific and
involving negative charges on the plasma membrane
(Carneiro et al., 2002). It is possible that EGCG or other
factors in the serum of subjects ingesting PSPC affect
the structure of the plasma membrane or the viral glyco-
protein. The heat-inactivation of serum in our studies
eliminated the non-specific effects of human comple-
ment at the viral envelope. Therefore, PSPC supplemen-
tation may provide additional factors that interfere with
virus binding at the cell surface. In addition, we cannot
exclude the possibility that alternative mechanisms alsoplay a role in the antiviral activity of PSPC supplementa-
tion such as effects at the cellular level, including the in-
activation of viral RNA polymerase or viral replication
enzymes, binding of viral nucleic acid or viral capsid pro-
teins, and suppression of virulence enzymes. PSPC con-
tains blueberry extract, a rich source of anthocyanins
and other polyphenols, that may induce antiviral effects
by mechanisms that are distinct from those exerted by
EGCG. Studies have suggested that in addition to affect-
ing virus attachment to host cells, anthocyanins may in-
hibit the infectivity of influenza virus by inhibiting the
cellular release of virus particles through binding to viral
neuraminidase (Swaminathan et al., 2013). Further stud-
ies will be carried out in order to investigate the exact
mechanisms by which PSPC supplementation interferes
with viral replication and killing of host cells.
The decreased resistance to virus infections during
intense exercise has been shown to be partially due to
the shift of balance towards the Th2 and away from the
Th1 immune response (Martin et al., 2009). Th1 inflam-
matory immune responses are critical for early antiviral
activity including elevated surveillance by macrophages
and dendritic cells, enhanced viral clearance, and mem-
ory responses. The protective effects of certain com-
pounds following intense exercise have been attributed
to the recovery of a Th1-type immune response leading
to improved antiviral effector functions (Murphy et al.,
2004). For example, ingestion of oat beta-glucan enhanced
macrophage function and improved the symptoms and
survival of exercise-stressed mice following intranasal
inoculation with HSV-1 (Davis et al., 2004). In our PSPC
study, there were no observable differences in cytokine
levels pre-exercise and post-exercise in placebo versus
supplemented groups (Nieman et al., 2013). However,
specific levels of Th1 cell-promoting factors such as IL-12,
IL-2 and IFNγ were not measured in serum samples from
subjects. Future studies will be aimed at determining
the levels of Th1 cytokines in the serum of individuals
following PSPC supplementation as further evidence of
the antiviral properties of this compound.
Serum from PSPC-supplemented subjects in our study
did not inhibit the growth of the gram negative bacteria,
E. coli, or the gram positive bacteria, S. aureus. Consis-
tent with our results, tea catechins have not been shown
to impact the growth of E. coli, but instead, they demon-
strate effectiveness by decreasing expression of viru-
lence factors such as those responsible for biofilm
formation and motility (Daglia, 2012). However, several
in vitro studies have shown that EGCG inhibits the
growth of S. aureus by binding to the positively charged
lipids of the bacterial cell membrane (Steinmann et al.,
2013). In addition, EGCG has been found to promote
antibacterial activity by sensitizing S. aureus strains to
the effects of specific antibiotics. It is possible that the
levels of EGCG in the serum of PSPC-supplemented
subjects were below the minimum inhibitory concentra-
tion for the S. aureus strain used in the study. EGCG is
poorly absorbed from the human small intestine, but
smaller phenolics following gut microbial degradation
are translocated to the circulation during intensive exer-
cise (Nieman et al., 2013). Little is known regarding the
influence of these gut-derived phenolics on antibacterial
activity. Alternatively, the effects of serum on bacteriamay involve effects that were not measured in our study
such as damage to the bacterial lipid layer or changes at
the level of gene expression. Because serum from sub-
jects ingesting PSPC exhibited antiviral properties, vi-
ruses may be more susceptible to the damaging effects
of polyphenolic compounds at the plasma membrane
than bacteria. In addition, the effect of polyphenols on
cellular immune and stress response pathways may have
more devastating downstream effects on intracellular
pathogens. Further studies are necessary to definitively
determine whether PSPC supplementation provides sol-
uble factors that exert antibacterial effects.
Although the virus used in our study, VSV, is not a hu-
man pathogen, it serves as an effective model system for
pathogenic human viruses due to its ability to replicate
in cells from a variety of different species (Johannsdottir
et al., 2009). Furthermore, it has been shown to infect
cells from different organ systems, including respiratory
epithelial cells and neurons. This study provides the
framework for future studies aimed at determining
whether the activity of PSPC in the serum of subjects
exerts activity against pathogenic human viruses such
as influenza virus, rhinovirus and HSV-1. Furthermore,
examining the mechanisms by which polyphenols in
PSPC interfere with the virus replication and exert antivi-
ral activity enables the development of novel polypheno-
lic combinations with synergistic anti-microbial effects.Conflict of Interest
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